Market Snapshot                             | Dow |          42518.28 |          +221.16 |                       (0.52%)            |                         | Nasdaq |          19044.39 |          -43.71 |                       (-0.23%)            |                         | SP 500 |          5846.53 |          +6.69 |                       (0.11%)            |                         | 10-yr Note  |          0/32 |          4.79 |          
  |                         
  |                         | NYSE |          Adv 2052 |           Dec 674 |           Vol 943 mln |                         | Nasdaq |          Adv 2524 |           Dec 1817 |           Vol 7.2 bln |                Industry Watch                             | Strong: Utilities, Materials, Real Estate, Financials, Industrials |                         
  |                         | Weak: Health Care, Communication Services, Information Technology, Consumer Staples, Energy |               
           Moving the Market                             -- Buy-the-dip interest aided by yesterday's turnaround and cooler-than-expected numbers in the December Producer Price Index 
  -- Some mega caps and chipmakers turned lower, limiting index performance 
  -- Outperformance of small caps
  -- Calm action in Treasuries
 
  |                    Closing Summary  14-Jan-25 16:30 ET  
  Dow +221.16           at 42518.28,       Nasdaq -43.71           at 19044.39,       S&P +6.69           at 5846.53 [BRIEFING.COM] The  stock market had a mixed session at the index level, but the vibe under  the surface was positive. Market participants were reacting to the  cooler-than-expected inflation data released at 8:30 ET, which garnered a  muted response from Treasuries and helped the upside bias in equities.  There was also some momentum in play after the stock market staged a  turnaround yesterday thanks to buy-the-dip interest. 
  The December  Producer Price Index (PPI) readings exceeded expectations, reflecting a  welcome easing in inflationary pressures on a month-to-month basis. The  year-over-year numbers were less market-friendly with PPI up 3.3%  versus 3.0% in November, and core-PPI, which excludes food and energy,  up 3.5%, unchanged from November. Treasuries still responded favorably,  leading the 10-yr yield settled two basis points lower at 4.79% and the  2-yr yield settled four basis points lower at 4.36%.
  The choppy moves in the major indices were related to volatility in the mega cap space. NVIDIA (NVDA 131.76, -1.47, -1.1%), Tesla (TSLA 396.36, -6.95, -1.7%), and Alphabet (GOOG 191.05, -1.24, -0.6%) traded lower with no specific news driving the movement while other names like Microsoft (MSFT 415.67, -1.52, -0.4%), Eli Lilly (LLY 744.91, -52.57, -6.6%), and Meta Platforms (META 594.25, -14.08, -2.3%) reacted negatively to headlines. 
  MSFT  reportedly paused hiring in its US consulting unit as part of a  cost-cutting plan, according to CNBC; LLY lowered Q4 revenue guidance;  and META reacted to reports that TikTok US is not going to be sold after  initial reporting suggested that may be the case.
  Small cap  stocks soared while mega cap languished, leading the Russell 2000 to  jump 1.1% from yesterday's close. This move was helped out by strength  in its regional bank components, which outperformed in front of earnings  reports from bank stocks this week.
  Strength in the bank space  also led the SPDR S&P Bank ETF (KBE) to close 3.3% higher and the  SPDR S&P Regional Banking ETF (KRE) to close 3.4%. The S&P 500  financial sector was among the top performers today, gaining 1.3%. 
 
 - S&P Midcap 400: +1.3% YTD
 - Dow Jones Industrial Average: -0.1% YTD
 - Russell 2000: -0.5% YTD
 - S&P 500: -0.7% YTD
 - Nasdaq Composite: -1.4% YTD
  Reviewing today's economic data:
 
 - December NFIB Small Business Optimism 105.1; Prior 101.7
 - December PPI 0.2% (Briefing.com consensus 0.3%); Prior 0.4%, December Core PPI 0.0% (Briefing.com consensus 0.2%); Prior 0.2%
- The  key takeaway from the report is that the better-than-expected monthly  readings have been clouded by the less inspiring year-over-year  readings, as well as the understanding that inflation at the wholesale  level moved in the wrong direction in 2024 (versus 2023) and remains  elevated relative to the Fed's 2% inflation target.
 
   Looking ahead, market participants receive the following economic data tomorrow:
 
 - 7:00 ET: Weekly MBA Mortgage Index (prior -3.7%)
 - 8:30  ET: December CPI (Briefing.com consensus 0.3%; prior 0.3%), Core CPI  (Briefing.com consensus 0.2%; prior 0.3%), and January Empire State  Manufacturing (Briefing.com consensus -2.0; prior 0.2)
 - 10:30 ET: Weekly crude oil inventories (prior -959,000)
 
  Treasuries settle with gains 14-Jan-25 15:35 ET  
  Dow +83.23           at 42380.35,       Nasdaq -118.68           at 18969.42,       S&P -14.32           at 5825.52 [BRIEFING.COM] The  major indices are trying to recover after the recent downturn. The  S&P 500 is down about 15 points, or 0.2%.
  The 10-yr yield settled two basis points lower at 4.79% and the 2-yr yield settled four basis points lower at 4.36%.
  Looking ahead, market participants receive the following economic data tomorrow:
 
 - 7:00 ET: Weekly MBA Mortgage Index (prior -3.7%)
 - 8:30  ET: December CPI (Briefing.com consensus 0.3%; prior 0.3%), Core CPI  (Briefing.com consensus 0.2%; prior 0.3%), and January Empire State  Manufacturing (Briefing.com consensus -2.0; prior 0.2)
 - 10:30 ET: Weekly crude oil inventories (prior -959,000)
 
  Mega caps take market lower, again 14-Jan-25 15:00 ET  
  Dow +59.63           at 42356.75,       Nasdaq -99.32           at 18988.78,       S&P -12.09           at 5827.75 [BRIEFING.COM] The  major indices turned slightly lower over the last half hour, but the Dow  Jones Industrial Average (+0.4%) remains near its high of the day.
  Downside moves coincided with some mega caps moving sharply lower. Meta Platforms (META 592.52, -15.75, -2.6%), Amazon.com (AMZN 217.42, -1.02, -0.5%), Microsoft (MSFT 414.68, -2.51, -0.6%), and NVIDIA (NVDA  130.60, -2.63, -2.0%) participated in the deterioration, weighing down  their respective S&P 500 sectors. The move in MSFT followed news  that the company paused hiring in its US consulting unit as part of a  cost-cutting plan, according to CNBC.
  The communication  services (-1.2%), information technology (-0.5%), and consumer  discretionary (-0.1%) sectors are among the worst performers today.
                 December Treasury deficit shrinks YoY, but Fiscal 2025 deficit up 39.4% 14-Jan-25 14:25 ET  
  Dow +220.00           at 42517.12,       Nasdaq +40.84           at 19128.94,       S&P +19.24           at 5859.08 [BRIEFING.COM] The  S&P 500 (+0.33%) has held its higher lines, little changed in  reaction to the December Treasury Budget which hit at the bottom of the  hour.
  The Treasury Budget for December showed a deficit of $86.7  billion compared to a deficit of $129.4 billion in the same period a  year ago. The December deficit resulted from outlays ($541 billion)  exceeding receipts ($454 billion). The Treasury Budget data are not  seasonally adjusted so the December deficit cannot be compared to the  November deficit of $366.7 billion.
  The key takeaway from the  report is that the deficit in early fiscal 2025 is 39.4% greater than  the deficit for the same period in fiscal 2024.
                 Gold edges higher as cooler inflation data boosts Fed rate-cut expectations 14-Jan-25 13:55 ET  
  Dow +221.82           at 42518.94,       Nasdaq +42.93           at 19131.03,       S&P +19.63           at 5859.47 [BRIEFING.COM] With  about two hours to go on Tuesday the tech-heavy Nasdaq Composite  (+0.22%) has climbed out of losses from the previous half hour; the  market expects the December Treasury Budget at the top of the hour, the  release delayed by a day in part due to last week's holiday related to  President Carter's funeral.
  Gold futures settled $3.70 higher (+0.1%) to $2,682.30/oz as cooler U.S. inflation data fueled Fed rate-cut hopes.
  Currently, the U.S. Dollar Index is down about -0.3% to $109.27.
                   Eli Lilly struggles to meet sky-high expectations as Q4 Mounjaro and Zepbound sales fall short (LLY)      Sales of Eli Lilly's (LLY)  blockbuster diabetes and weight loss drugs, Mounjaro and Zepbound, are  very strong, but they're not quite as robust as the company and analysts  had anticipated in Q4. Therefore, the company issued downside Q4  revenue guidance of $13.5 bln, igniting a sharp selloff in the stock  that has now taken shares lower by about 24% from the record highs set  last August.
  The pharmaceutical giant also guided for FY25  revenue of $58-$61 bln, equating to estimated yr/yr growth of  approximately 32% and beating expectations at the midpoint of the range.  However, the lofty expectations and rich valuation -- LLY is currently  trading with a 1-year Forward P/E of 35x -- is leaving little room for  error and the company's second straight quarterly revenue miss is enough  of a blemish to instigate a pullback.
 
 - Rewinding to last  quarter, the story was much the same as today. While demand for Mounjaro  and Zepbound was very strong, as reflected by Mounjaro sales surging by  121% yr/yr to $3.11 bln and Zepbound generating sales of nearly $1.3  bln, inventory decreases in the wholesale channel prevented growth from  being even stronger. LLY estimated that these decreases negatively  impacted Q3 sales of Mounjaro and Zepbound by a mid-single-digit rate.
 - Similarly,  in this morning's press release, LLY cited lower-than-expected channel  inventory as a factor in its softer-than-expected Q4 results.  Furthermore, the anticipated bump in December sales that typically  results from customers bolstering prescriptions before deductibles reset  in January did not play out as expected. 
 - Looking beyond  Mounjaro and Zepbound, most of LLY's portfolio is also performing quite  well. In fact, its non-incretin products generated strong growth of 20%  in Q4, marking an acceleration from last quarter's growth of 17%.  Verzenio, a treatment for metastatic breast cancer, has been a standout  with sales up by 37% in Q3, while autoimmune disease drug Taltz has also  seen solid growth. The clear laggard has been Trulicity, a  diabetes/weight loss drug that has been cannibalized by the surge in  sales for Mounjaro and Zepbound. In Q3, Trulicity sales tumbled by 22%  to $1.30 bln.
  The main takeaway is that business is still  quite strong for LLY and that FY25 is setting up to be another highly  successful year, led by high double-digit growth for Mounjaro and  Zepbound. Expectations are sky-high for the company, so any  disappointment is going to be amplified, but many companies --  especially mature pharmaceutical companies -- would gladly accept 30%+  top-line growth.
              Amazon reportedly planning to rearchitect Alexa with Gen AI; hallucinations prove tall hurdle (AMZN)      
  Amazon (AMZN)  initially saw decent gains today before the move faded, keeping the  stock on a modest downward trajectory since reaching record highs last  month. The jump to kickstart today's trading session was supported by an  FT report surrounding the e-commerce and cloud giant's plans  to re-introduce its Alexa assistant as an AI product, following in the  footsteps of its big tech counterparts, including Google (GOOG) and Apple (AAPL).
     AMZN has hinted at its desire to rearchitect Alexa's "brain" with a  new set of foundation models as it increasingly adds more AI to all of  its devices. For instance, its new Kindle Scribe, which was announced  late last year, possesses a built-in AI-powered notebook, enabling rapid  summarizing of notes. This device, combined with AMZN's Kindle  Paperwhite, which now touts a color screen, as well as the new  pocket-sized Kindle, saw outsized sales within the first few weeks of  launch, exceeding management's expectations.
    While it is unclear  how much AI has influenced customers' buying decisions, it could be a  deciding factor when weighing competing products. AMZN is slightly  behind surrounding retail consumer-focused AI. While AWS is leveraging  advanced AI capabilities, AMZN's consumer electronics continue to come  with an increasingly outdated Alexa voice assistant when stacked against  its peers. For instance, Google's Gemini assistant has featured AI for  over a year, while Apple's Siri received a major overhaul a few months  ago and is now integrated with ChatGPT (MSFT). 
 
 - AMZN  falling behind is a consequence of struggling to eliminate AI  hallucinations, where the model makes up an answer instead of disclosing  that it cannot find information on the topic. Hallucinations remain a  nagging problem across all large language models (LLMs). Numerous  companies, from those in AI to other unrelated verticals, have discussed  the risk of hallucination in their AI-powered chatbots. For instance, Meta Platforms (META) noted last year that rushing AI to market has resulted in considerable hallucination rates. 
 - AMZN  wants Alexa to be embedded across an individual's home, turning on  lights, playing music, closing blinds, etc. With Alexa trying to be more  than a personal phone assistant, hallucinations can shut the door on  adoption, making it critical to avoid these issues before launch, which  has created some delays. 
 -  Still, revamping Amazon Alexa is more  of a matter of when than if. During AMZN's Q3 earnings call in October,  CFO Brian Olsavsky commented that a Gen-AI-powered Alexa is absolutely  going to happen. With around 500 mln Alexa-enabled devices across the  globe, AMZN has the potential to quickly become an AI leader within the  consumer tech world. The company will not want to pass up this  opportunity. 
   AMZN has high ambitions surrounding Alexa,  given that the assistant is used across homes, offices, vehicles, and  within the hospitality industry. Given the sophistication of LLMs, Alexa  can act as a powerful personal assistant. However, hallucinations can  quickly damage an AI model's reputation, making it crucial that AMZN  gets this right on the first go-around. 
              KB Home building solid gains after upside Q4 results, but high mortgage rates still an issue (KBH)      The homebuilding industry has shown some  cracks in its foundation recently as stubbornly high mortgage rates have  forced new construction companies to remain in a promotional mode in  order to ease affordability headwinds, but KB Home's (KBH)  better-than-expected Q4 results are providing the space with a  much-needed boost. Buoyed by a healthy labor market and favorable  demographics, demand for new homes was strong in Q4, as illustrated by  KBH's 40% yr/yr increase in net orders in Q4.
  With shares of KBH  diving by 23% since the beginning of December, the stock was primed for a  rebound and KBH's quarterly results and outlook helped ease concerns  that business conditions are continuing to deteriorate for the company  and the overall industry. However, KBH and others aren't out of the  woods just yet as high mortgage rates are still presenting an obstacle.
 
 - On  that note, KBH stated during the earnings call that despite two  interest rate cuts from the Fed totaling 75 basis points, mortgage rates  actually increased from September to October, and then again in  November. As a result, some potential home buyers held back on purchase  decisions -- especially during the last two months of Q4 -- causing the  company to fall short of its internal sales goal. 
 - This  hesitancy has continued into Q4, putting some pressure on net orders.  For the first six weeks of 1Q25, net orders are down by 12% yr/yr to  1,026, but KBH does expect net orders to pick up as it enters the  stronger spring selling season. Furthermore, KBH has been able to  improve its build times by an average of 28%, leading to a 17% jump in  deliveries in Q4 to 3,978.
 - Additionally, KBH held firm on its  base prices -- average selling price rose by 3% to $501,000 -- while  direct costs, such as lumber and concrete, also decreased in the closing  months of FY24. These factors helped to offset the impact from  incentives, including mortgage rate buydowns or locks, which were  provided to about 60% of KBH's customers in Q4. Taken altogether,  adjusted housing gross profit margin ticked higher by 20 bps  sequentially to 20.9%.
 - Encouragingly, the company anticipates  housing gross profit margin to remain stable in FY25 at 20.0-21.0%, even  as tariffs under the new Trump Administration potentially drive up the  costs of U.S. produced materials. Through volume-based pricing, the  company believes that it can offset the impact of rising costs from  tariffs.
  Overall, KBH's Q4 results and FY25 guidance were  solid and reinforced the notion that the homebuilding industry is in  relatively healthy shape, but persistently higher mortgage rates are  still a barrier to stronger growth and higher margins.
              Signet Jewelers (SIG) shares tarnished by weak holiday sales, lowered guidance (SIG)      
  Signet Jewelers' (SIG -21%) holiday  sales trends fell short, leading the jewelry retailer to cut its Q4  (Jan) revenue forecast by roughly $93 mln when taking the midpoint. SIG  now anticipates final quarter revenue of $2.320-2.335 bln, translating  to an approximately 7% drop yr/yr and marking SIG's ninth consecutive  quarter of yr/yr sales compression. Meanwhile, total same-store sales  decreased by around -2% during the season, driving SIG's slashed Q4 comp  outlook to negative 2.0-2.5% versus its previous flat to +3% target. 
 
 - What went wrong?  Consumers gravitated toward lower price points more than SIG  anticipated during the holidays, flocking to many of the company's  lower-priced rivals. For instance, Costco (COST) mentioned  last week that non-food items enjoyed high teen percentage growth in  December, with jewelry being among the better-performing categories. 
 - Last  month, SIG noted that it had room to engage in some promotional  activity to defend against competitive pressures, adding that its  initial Q4 guidance, which met analyst expectations, provided enough  flexibility within its view of gross margins. Unfortunately, SIG stated  today that merchandise assortment gaps were apparent across critical  gifting price points during the holidays, hindering its ability to lure  enough customers to boost sales. 
 - There were a few silver  linings from the holiday season. For example, SIG's Engagement and  Service division saw sales trends meet expectations. Furthermore,  average unit retail ticked higher across Bridal and Fashion businesses,  edging 5% higher overall. However, CEO J.K. Symancyk, who took over in  November following Virginia Drosos's retirement, conceded that SIG could  do better, adding that meaningful potential has yet to be uncovered. 
  With  shares tracking near two-year lows, the question now is where SIG goes  from here to reengage investors. The company is operating at a time when  lower-priced merchants are scooping up customers, and close peers, such  as Pandora (PANDY), continuously conduct the right  moves to deliver growth despite a challenging economic environment. For  instance, Pandora posted 8% like-for-like growth during the first nine  months of 2024 versus SIG's -4.6% comp growth over that same period  despite lapping a much more favorable -12.6% comp in the year-ago  period. 
  Falling short of expectations during December, which  tends to see twice the number of engagements compared to every other  month, is a troubling setback, especially since it can often provide  much-needed momentum heading into the new year. Without this wind at its  back, SIG may need to lean more on promotions going forward to  reenergize its top line. However, this can squeeze profitability,  bottlenecking earnings upside in future quarters unless SIG turns to  aggressive cost-cutting. Meanwhile, even though inflationary pressures  have not reaccelerated, their cumulative effects are weighing on the  consumer, which could ultimately cause SIG to struggle to dazzle  investors over the near term. 
              WD-40 slips to six-month lows on unchanged FY25 guidance despite upbeat Q1 numbers (WDFC)      
  WD-40 (WDFC -6%) slips  today despite topping earnings and sales estimates in Q1 (Nov). Today's  lackluster response stems primarily from the multi-use product maker,  known most for its WD-40 brand, reiterating its FY25 (Aug) outlook even  after delivering meaningful top and bottom-line upside in the quarter.  It is important to note that last quarter WDFC issued downbeat FY25  guidance, projecting earnings markedly below consensus at $5.20-5.45 on  pro forma revenue growth of +6-11%. By not hiking its previously lowered  guidance, WDFC is signaling some headwinds ahead. 
 
 - WDFC's  reiterated FY25 guidance incorporates the possibility that trends will  begin to slow moving forward. For instance, in Q1, EPS expanded by  around 9% to $1.39. To reach the midpoint of its FY25 outlook, WDFC must  register average earnings of around $1.31 for the next three quarters.  Likewise, WDFC's FY25 sales outlook includes the potential for growth to  weaken following a 9.2% increase in Q1 to $153.3 mln. 
 - The  Asia-Pacific region, including Australia, China, and others, is  potentially weighing on future growth. During Q1, sales in this region  contracted by 4% yr/yr to $26.6 mln, driven by lower sales of the  company's core product in Asia distributor markets. 
 -  On the  bright side, prospects in WDFC's primary Americas region remain healthy.  During Q1, sales edged 8% higher in the area to $69.4 mln, supported by  the company's namesake WD-40 brand and higher sales volumes linked to  promotional activities. Management added that nothing stood out  surrounding large volume promotions that boosted sales. Rather, the home  center channel in the U.S. stayed strong during the quarter, and retail  sales have picked up as retail foot traffic and DIY activity appear to  be improving. 
 - Meanwhile, in the EIMEA region, which includes  India, sales surged by 18% yr/yr to $57.5 mln, bolstered by a 19% jump  in maintenance products and a 21% increase in WDFC's core product. While  the Asian Pacific sales were disappointing, WDFC's success in EIMEA  underscores progress within the geographic expansion component of its  "Must-Win Battles" framework. 
-  Other pieces of WDFC's "Must-Win  Battles" include driving higher sales of its premium formats of WD-40,  which act as a major contributor to its top and bottom lines, and  driving WD-40 Specialist growth, which expanded by 14% yr/yr in Q1. 
 
  -   A final item to note is WDFC's homecare and cleaning product portfolio,  which continues to experience declining sales growth. The company is  looking to divest this business, targeting a Q2 (Feb) sale. As such,  WDFC backed out this business in its FY25 revenue growth outlook. 
  WDFC  delivered a decent performance in Q1. However, without it flowing into  the company's FY25 guidance, investors are left wanting more. The  unchanged guidance may also keep sellers in control over the near term  until WDFC expresses more confidence in a brighter back half of the  year.
           |